BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23250007)

  • 1. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.
    Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M
    Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against
    Zhang BZ; Hu D; Dou Y; Xiong L; Wang X; Hu J; Xing SZ; Li W; Cai JP; Jin M; Zhang M; Lin Q; Li M; Yuen KY; Huang JD
    Front Immunol; 2021; 12():730116. PubMed ID: 34745099
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-immunization with DNA vaccines encoding yidR and IL-17 augments host immune response against
    Lv Z; Zhang X; Zhao K; Du L; Wang X; Chu Y; Huang T
    Virulence; 2024 Dec; 15(1):2345019. PubMed ID: 38656137
    [No Abstract]   [Full Text] [Related]  

  • 6. A promising bioconjugate vaccine against hypervirulent
    Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection.
    Liao J; Zhang X; Zeng X; Zhao Z; Sun T; Xia Z; Jing H; Yuan Y; Chen Z; Gou Q; Zhao L; Zhang W; Zou Q; Zhang J
    Biomed Pharmacother; 2024 May; 174():116611. PubMed ID: 38643540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection.
    Malachowa N; Kobayashi SD; Porter AR; Freedman B; Hanley PW; Lovaglio J; Saturday GA; Gardner DJ; Scott DP; Griffin A; Cordova K; Long D; Rosenke R; Sturdevant DE; Bruno D; Martens C; Kreiswirth BN; DeLeo FR
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848292
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.
    Kurupati P; Teh BK; Kumarasinghe G; Poh CL
    Proteomics; 2006 Feb; 6(3):836-44. PubMed ID: 16372264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.
    Kurupati P; Ramachandran NP; Poh CL
    Clin Vaccine Immunol; 2011 Jan; 18(1):82-8. PubMed ID: 21048001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars].
    Kurbatova EA; Egorova NB; Kiseleva BS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the immunogenicity of a monopreparation of Klebsiella pneumoniae antigen complex and its association with Staphylococcus, Proteus and Escherichia coli antigens].
    Egorova NB; Mansurova NL; Kurbatova EA; Efremova VN; Kreĭnin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):35-8. PubMed ID: 6367319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae.
    Jain RR; Mehta MR; Bannalikar AR; Menon MD
    Biologicals; 2015 May; 43(3):195-201. PubMed ID: 25737397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].
    Kurbatova EA; Lazareva ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit.
    Wang Q; Chang CS; Pennini M; Pelletier M; Rajan S; Zha J; Chen Y; Cvitkovic R; Sadowska A; Heidbrink Thompson J; Yu Lin H; Barnes A; Rickert K; Wilson S; Stover CK; Dall'Acqua WF; Chowdhury PS; Xiao X
    J Infect Dis; 2016 Jun; 213(11):1800-8. PubMed ID: 26768253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice.
    Kumar A; Harjai K; Chhibber S
    Microb Pathog; 2020 Jul; 144():104161. PubMed ID: 32194179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens.
    Cooper JM; Rowley D
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):629-41. PubMed ID: 6820634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel chimeric vaccine containing multiple epitopes for simulating robust immune activation against Klebsiella pneumoniae.
    Hakimian M; Doosti A; Sharifzadeh A
    BMC Immunol; 2024 May; 25(1):27. PubMed ID: 38706005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
    Lavender H; Jagnow JJ; Clegg S
    Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring
    Dey J; Mahapatra SR; Lata S; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2022 Apr; 21(4):569-587. PubMed ID: 34932430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.